Megan Kennedy

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Tim Maughan, Richard Adams, Christopher G. Smith et al. · The Lancet · 2011 · 964 citations

Gastrointestinal Oncology, Medicine, Randomised Phase 3 +8

Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer

José Baselga, Patricia Gómez, Richard Greil et al. · Journal of Clinical Oncology · 2013 · 350 citations · Full text

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Richard Adams, Angela Meade, Richard H. Wilson et al. · The Lancet Oncology · 2011 · 262 citations · Full text

Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy

John V. Reynolds, Narayanasamy Ravi, Donal Hollywood et al. · Journal of Thoracic and Cardiovascular Surgery · 2006 · 125 citations

Neoadjuvant Chemoradiation, Surgical Oncology, Esophagus +12

Improvement in histological endpoints of MAFLD following a 12‐week aerobic exercise intervention

Philip O’Gorman, Sara Naimimohasses, Ann Monaghan et al. · Alimentary Pharmacology & Therapeutics · 2020 · 86 citations